Evolent Health (EVH) Competitors

$4.42 +0.15 (+3.58%)

As of 02:46 PM Eastern

EVH vs. FLYW, NVRI, STGW, BRAI, and CNXC

Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include Flywire (FLYW), Enviri (NVRI), Stagwell (STGW), Braiin (BRAI), and Concentrix (CNXC). These companies are all part of the "business services" industry.

How does Evolent Health compare to Flywire?

Evolent Health (NYSE:EVH) and Flywire (NASDAQ:FLYW) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

Flywire has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Flywire, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.26	-$534.51M	-$5.15	N/A
Flywire	$623.03M	3.41	$13.50M	$0.10	175.05

Evolent Health has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Flywire has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500.

In the previous week, Flywire had 15 more articles in the media than Evolent Health. MarketBeat recorded 24 mentions for Flywire and 9 mentions for Evolent Health. Flywire's average media sentiment score of 0.77 beat Evolent Health's score of 0.33 indicating that Flywire is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Flywire	6 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Evolent Health presently has a consensus price target of $6.12, indicating a potential upside of 38.26%. Flywire has a consensus price target of $18.17, indicating a potential upside of 3.78%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts clearly believe Evolent Health is more favorable than Flywire.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71
Flywire	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.50

Flywire has a net margin of 4.45% compared to Evolent Health's net margin of -28.49%. Flywire's return on equity of 3.82% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-28.49%	1.49%	0.49%
Flywire	4.45%	3.82%	2.59%

95.9% of Flywire shares are held by institutional investors. 1.5% of Evolent Health shares are held by company insiders. Comparatively, 4.4% of Flywire shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Flywire beats Evolent Health on 12 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Enviri?

Enviri (NYSE:NVRI) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Enviri has a net margin of -7.62% compared to Evolent Health's net margin of -28.49%. Evolent Health's return on equity of 1.49% beat Enviri's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enviri	-7.62%	-13.47%	-1.92%
Evolent Health	-28.49%	1.49%	0.49%

Enviri presently has a consensus price target of $25.00, indicating a potential upside of 29.63%. Evolent Health has a consensus price target of $6.12, indicating a potential upside of 38.26%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than Enviri.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enviri	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Evolent Health	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71

Enviri has higher revenue and earnings than Evolent Health. Enviri is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enviri	$2.24B	0.71	-$167.60M	-$2.12	N/A
Evolent Health	$1.88B	0.26	-$534.51M	-$5.15	N/A

93.4% of Enviri shares are owned by institutional investors. 2.5% of Enviri shares are owned by insiders. Comparatively, 1.5% of Evolent Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Enviri has a beta of 1.59, indicating that its stock price is 59% more volatile than the S&P 500. Comparatively, Evolent Health has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.

In the previous week, Enviri had 1 more articles in the media than Evolent Health. MarketBeat recorded 10 mentions for Enviri and 9 mentions for Evolent Health. Enviri's average media sentiment score of 0.62 beat Evolent Health's score of 0.33 indicating that Enviri is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enviri	2 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Evolent Health	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Enviri beats Evolent Health on 10 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Stagwell?

Stagwell (NASDAQ:STGW) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

35.6% of Stagwell shares are held by institutional investors. 5.6% of Stagwell shares are held by insiders. Comparatively, 1.5% of Evolent Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Stagwell had 1 more articles in the media than Evolent Health. MarketBeat recorded 10 mentions for Stagwell and 9 mentions for Evolent Health. Stagwell's average media sentiment score of 0.47 beat Evolent Health's score of 0.33 indicating that Stagwell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stagwell	4 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Evolent Health	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Stagwell has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stagwell	$2.91B	0.57	$29.10M	$0.07	92.64
Evolent Health	$1.88B	0.26	-$534.51M	-$5.15	N/A

Stagwell has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Comparatively, Evolent Health has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.

Stagwell has a net margin of 0.64% compared to Evolent Health's net margin of -28.49%. Stagwell's return on equity of 24.12% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stagwell	0.64%	24.12%	4.31%
Evolent Health	-28.49%	1.49%	0.49%

Stagwell currently has a consensus price target of $7.71, indicating a potential upside of 18.86%. Evolent Health has a consensus price target of $6.12, indicating a potential upside of 38.26%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than Stagwell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stagwell	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44
Evolent Health	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71

Summary

Stagwell beats Evolent Health on 13 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Braiin?

Braiin (NASDAQ:BRAI) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Evolent Health has a consensus price target of $6.12, indicating a potential upside of 38.26%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts clearly believe Evolent Health is more favorable than Braiin.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Braiin	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Evolent Health	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71

Braiin has higher earnings, but lower revenue than Evolent Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Braiin	$73.41M	20.49	N/A	N/A	N/A
Evolent Health	$1.88B	0.26	-$534.51M	-$5.15	N/A

In the previous week, Braiin and Braiin both had 9 articles in the media. Evolent Health's average media sentiment score of 0.33 beat Braiin's score of 0.09 indicating that Evolent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Braiin	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Evolent Health	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Braiin has a net margin of 0.00% compared to Evolent Health's net margin of -28.49%. Evolent Health's return on equity of 1.49% beat Braiin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Braiin	N/A	N/A	N/A
Evolent Health	-28.49%	1.49%	0.49%

Summary

Evolent Health beats Braiin on 7 of the 9 factors compared between the two stocks.

How does Evolent Health compare to Concentrix?

Concentrix (NASDAQ:CNXC) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Concentrix has a net margin of -13.35% compared to Evolent Health's net margin of -28.49%. Concentrix's return on equity of 17.80% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Concentrix	-13.35%	17.80%	5.45%
Evolent Health	-28.49%	1.49%	0.49%

Concentrix presently has a consensus price target of $48.50, indicating a potential upside of 97.96%. Evolent Health has a consensus price target of $6.12, indicating a potential upside of 38.26%. Given Concentrix's higher probable upside, analysts clearly believe Concentrix is more favorable than Evolent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concentrix	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Evolent Health	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71

90.3% of Concentrix shares are owned by institutional investors. 0.9% of Concentrix shares are owned by insiders. Comparatively, 1.5% of Evolent Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Evolent Health has lower revenue, but higher earnings than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concentrix	$9.83B	0.15	-$1.28B	-$21.55	N/A
Evolent Health	$1.88B	0.26	-$534.51M	-$5.15	N/A

In the previous week, Evolent Health had 1 more articles in the media than Concentrix. MarketBeat recorded 9 mentions for Evolent Health and 8 mentions for Concentrix. Concentrix's average media sentiment score of 0.39 beat Evolent Health's score of 0.33 indicating that Concentrix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Concentrix	3 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Evolent Health	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Concentrix has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500. Comparatively, Evolent Health has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.

Summary

Evolent Health beats Concentrix on 9 of the 16 factors compared between the two stocks.

Get Evolent Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EVH vs. The Competition

Export

Metric	Evolent Health	INTERNET SOFTWARE Industry	Computer Sector	NYSE Exchange
Market Cap	$488.43M	$16.33B	$38.68B	$22.87B
Dividend Yield	N/A	4.45%	3.16%	4.01%
P/E Ratio	-0.85	70.59	73.81	28.31
Price / Sales	0.26	39.54	617.74	23.86
Price / Cash	0.82	64.40	46.83	25.49
Price / Book	1.25	6.33	9.50	4.66
Net Income	-$534.51M	$379.25M	$1.03B	$1.07B
7 Day Performance	N/A	N/A	N/A	-0.56%
1 Month Performance	72.44%	16.41%	14.52%	4.39%
1 Year Performance	-58.93%	3.43%	170.62%	28.95%

Evolent Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EVH Evolent Health	2.6973 of 5 stars	$4.42 +3.6%	$6.12 +38.3%	-58.9%	$488.43M	$1.88B	N/A	4,200	News Coverage Earnings Report Analyst Forecast
FLYW Flywire	4.0065 of 5 stars	$14.00 +3.6%	$16.18 +15.6%	+63.3%	$1.64B	$623.03M	140.01	1,400	Earnings Report Analyst Forecast
NVRI Enviri	1.9536 of 5 stars	$19.65 -0.2%	$25.00 +27.2%	+169.9%	$1.63B	$2.24B	N/A	12,000
STGW Stagwell	3.4857 of 5 stars	$6.36 +1.4%	$7.96 +25.3%	+11.3%	$1.59B	$2.91B	79.44	12,629	Analyst Forecast Insider Trade
BRAI Braiin	N/A	$7.39 +5.1%	N/A	N/A	$1.52B	$73.41M	N/A	5	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EVH) was last updated on 5/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evolent Health (EVH) Competitors

EVH vs. FLYW, NVRI, STGW, BRAI, and CNXC

How does Evolent Health compare to Flywire?

Summary

How does Evolent Health compare to Enviri?

Summary

How does Evolent Health compare to Stagwell?

Summary

How does Evolent Health compare to Braiin?

Summary

How does Evolent Health compare to Concentrix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evolent Health (EVH) Competitors

EVH vs. FLYW, NVRI, STGW, BRAI, and CNXC

How does Evolent Health compare to Flywire?

Which has preferable valuation and earnings, EVH or FLYW?

Which has more risk and volatility, EVH or FLYW?

Does the media refer more to EVH or FLYW?

Do analysts rate EVH or FLYW?

Is EVH or FLYW more profitable?

Do institutionals & insiders believe in EVH or FLYW?

Summary

How does Evolent Health compare to Enviri?

Is NVRI or EVH more profitable?

Do analysts recommend NVRI or EVH?

Which has better valuation & earnings, NVRI or EVH?

Do insiders and institutionals believe in NVRI or EVH?

Which has more volatility & risk, NVRI or EVH?

Does the media prefer NVRI or EVH?

Summary

How does Evolent Health compare to Stagwell?

Do institutionals and insiders believe in STGW or EVH?

Does the media favor STGW or EVH?

Which has stronger earnings and valuation, STGW or EVH?

Which has more volatility & risk, STGW or EVH?

Is STGW or EVH more profitable?

Do analysts rate STGW or EVH?

Summary

How does Evolent Health compare to Braiin?

Do analysts prefer BRAI or EVH?

Which has higher earnings & valuation, BRAI or EVH?

Does the media prefer BRAI or EVH?

Is BRAI or EVH more profitable?

Summary

How does Evolent Health compare to Concentrix?

Is CNXC or EVH more profitable?

Do analysts prefer CNXC or EVH?

Do institutionals & insiders have more ownership in CNXC or EVH?

Which has higher earnings & valuation, CNXC or EVH?

Does the media prefer CNXC or EVH?

Which has more risk & volatility, CNXC or EVH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools